-
North Korea acknowledges its troops cleared mines for Russia
-
US unseals warrant for tanker seized off Venezuelan coast
-
Cambodia says Thailand still bombing hours after Trump truce call
-
Machado urges pressure so Maduro understands 'he has to go'
-
Leinster stutter before beating Leicester in Champions Cup
-
World stocks mostly slide, consolidating Fed-fuelled gains
-
Crypto firm Tether bids for Juventus, is quickly rebuffed
-
Union sink second-placed Leipzig to climb in Bundesliga
-
US Treasury lifts sanctions on Brazil Supreme Court justice
-
UK king shares 'good news' that cancer treatment will be reduced in 2026
-
Wembanyama expected to return for Spurs in NBA Cup clash with Thunder
-
Five takeaways from Luigi Mangione evidence hearings
-
UK's king shares 'good news' that cancer treatment will be reduced in 2026
-
Steelers' Watt undergoes surgery to repair collapsed lung
-
Iran detains Nobel-prize winner in 'brutal' arrest
-
NBA Cup goes from 'outside the box' idea to smash hit
-
UK health service battles 'super flu' outbreak
-
Can Venezuela survive US targeting its oil tankers?
-
Democrats release new cache of Epstein photos
-
Colombia's ELN guerrillas place communities in lockdown citing Trump 'intervention' threats
-
'Don't use them': Tanning beds triple skin cancer risk, study finds
-
Nancy aims to restore Celtic faith with Scottish League Cup final win
-
Argentina fly-half Albornoz signs for Toulon until 2030
-
Trump says Thailand, Cambodia have agreed to stop border clashes
-
Salah in Liverpool squad for Brighton after Slot talks - reports
-
Marseille coach tips Greenwood as 'potential Ballon d'Or'
-
Draw marks 'starting gun' toward 2026 World Cup, Vancouver says
-
Thai PM says asked Trump to press Cambodia on border truce
-
Salah admired from afar in his Egypt home village as club tensions swirl
-
World stocks retrench, consolidating Fed-fuelled gains
-
Brazil left calls protests over bid to cut Bolsonaro jail time
-
Trump attack on Europe migration 'disaster' masks toughening policies
-
US plan sees Ukraine joining EU in 2027, official tells AFP
-
'Chilling effect': Israel reforms raise press freedom fears
-
Iran frees child bride sentenced to death over husband's killing: activists
-
No doubting Man City boss Guardiola's passion says Toure
-
Youthful La Rochelle name teen captain for Champions Cup match in South Africa
-
World stocks consolidate Fed-fuelled gains
-
British 'Aga saga' author Joanna Trollope dies aged 82
-
Man Utd sweat on Africa Cup of Nations trio
-
EU agrees three-euro small parcel tax to tackle China flood
-
Taylor Swift breaks down in Eras documentary over Southport attack
-
Maresca 'relaxed' about Chelsea's rough patch
-
France updates net-zero plan, with fossil fuel phaseout
-
Nowhere to pray as logs choke flood-hit Indonesian mosque
-
In Pakistan, 'Eternal Love' has no place on YouTube
-
England bowling great Anderson named as Lancashire captain
-
UK's King Charles to give personal TV message about cancer 'journey'
-
Fit-again Jesus can be Arsenal's number one striker, says Arteta
-
Spain's ruling Socialists face sex scandal fallout among women voters
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use
HAYWARD, CALIFORNIA / ACCESS Newswire / July 29, 2025 / Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use. The media and chambers were part of Biolog's acquisition of Anaerobe Systems earlier this year with the objective of bringing class-leading tools for microbiology to the rapidly growing clinical, microbiome, and agricultural markets.
Today, Biolog's TruPRAS™ media is the only commercial media manufactured under true pre-reduced, anaerobically sterilized conditions, preventing the formation of harmful byproducts that can be toxic to anaerobic organisms. This line of media products, which has been approved for In Vitro Diagnostic (IVD) use by the USA FDA for years, has now also achieved CE marking under the requirements of the EU IVDR regulation 2017/746. With zero recalls or field actions throughout their extensive history, these products enable transport of specimens and growth of fastidious anaerobes that play important roles in disease pathology - supporting clinical diagnostics in medical laboratories.
"The IVDR/CE mark is a major milestone that recognizes the high standard of our anaerobic media and its value in supporting critical diagnostic workflows," said Robert Wicke, CEO at Biolog. "We're proud that clinical labs throughout Europe can now benefit from the same reliable performance that researchers and clinicians in the U.S. have trusted for decades."
Biolog's anaerobic chambers have also received the CE mark, affirming their safety and performance for use in any research settings throughout the world. With unique InstaSleeve™ technology, these ergonomic, gloveless chambers offer superior processing dexterity while working in a fully anaerobic environment and are a preferred tool for microbiologists in both clinical and academic settings. In addition, Biolog is releasing an upgrade to enable hypoxic or microaerophilic conditions in the same chamber, for organisms that require specific, low concentrations of oxygen to thrive.
"This dual achievement reinforces Biolog's commitment to advancing global access to high-quality tools for anaerobic microbiology," said Wicke. "Whether you're working with challenging clinical isolates or conducting fundamental research, Biolog now provides dependable CE-marked solutions that meet your needs."
About Biolog
Biolog offers tools, services, and support for comprehensive cellular characterization and multi-omic identification of bacteria, yeast, and fungi. Our products also enable phenotypic profiling of microbial and mammalian cells for a range of applications, including supporting the culture of fastidious anaerobes with our line of gloveless chambers and pre-reduced media. Learn more at biolog.com
Contact Information
John Proctor, Ph.D.
CCO
[email protected]
(408)306-0414
SOURCE: Biolog, Inc.
View the original press release on ACCESS Newswire
K.Hill--AT